Prof. Igor Belenichev | Machine Learning | Excellence in Innovation

Prof. Igor Belenichev | Machine Learning | Excellence in Innovation

Professor at Zaporizhzhia State Medical University, Ukraine

Profiles

Scopus

Orcid

Google Scholar

📚 Summary

Prof. Igor Fedorovich Belenichev is a distinguished Full Professor and Head of the Department of Pharmacology and Medical Formulation at Zaporizhzhia State Medical University. Renowned for his innovative research in neuroprotection and pharmacology, he is a laureate of the Cabinet of Ministers of Ukraine Prize for the development and implementation of groundbreaking technologies.

Education

  • Zaporizhzhia State Medical Institute (1988): Graduated with a degree in medicine.
  • Postgraduate studies (1988), professor assistant (1991), senior teacher (1999), associate professor (2004), and full professor (2006).

💼 Professional Experience

  • Zaporizhzhia State Medical University: Head of the Department of Pharmacology and Medical Formulation since 2005.
  • Main Scientific Researcher at «Pharmatrone» (since 1993).
  • Head of the regional branch of the Association of Pharmacologists of Ukraine.
  • Co-worker of the regional group of the National Expert Centre of the Ministry of Health of Ukraine.

🔬 Research Interests

Prof. Belenichev’s research focuses on the molecular and biochemical mechanisms of ischemic brain damage and the development of effective neuroprotectors. His work explores the roles of reactive oxygen and nitrogen species, thiol-disulfide systems, pro-/anti-apoptotic proteins, estrogen receptors, and endogenous neuroprotection factors. He also investigates drugs for CNS pathologies and effective neuro- or cardioprotectors from derivatives of 1,2,4-triazole, chinazoline, and xanthine.

🏆 Achievements

  • Scientific Works: Authored and co-authored 715 scientific publications.
  • Patents: Holder of 182 patents in Ukraine and the Russian Federation.
  • Theses: Supervised 3 Dr. Habs and 7 Ph.D. theses.
  • Drug Development: Contributed to the creation of drugs like Thiotriazoline, Thiocetam, and Thiodarone.
  • Awards: Token of the Bibliographical Society of America (2003), Regional Program “Zoryaniy Shlyakh” Prize (2000), and Cabinet of Ministers of Ukraine Prize (2017).

 

Publications

5+1-Heterocyclization as preparative approach for carboxy-containing triazolo[1,5-c]quinazolines with anti-inflammatory activity

  • Authors: Krasovska, Natalya; Berest, Galina; Belenichev, Igor; Severina, Hanna; Nosulenko, Inna; Voskoboinik, Oleksii; Okovytyy, Sergiy; Kovalenko, Serhii
  • Journal: European Journal of Medicinal Chemistry
  • Year: 2024

Beta-Blockers of Different Generations: Features of Influence on the Disturbances of Myocardial Energy Metabolism in Doxorubicin-Induced Chronic Heart Failure in Rats

  • Authors: Igor Belenichev; Olexiy Goncharov; Nina Bukhtiyarova; Oleh Kuchkovskyi; Victor Ryzhenko; Lyudmyla Makyeyeva; Valentyn Oksenych; Oleksandr Kamyshnyi
  • Journal: Biomedicines
  • Year: 2024

Characteristics of HIF-1α and HSP70 mRNA Expression, Level, and Interleukins in Experimental Chronic Generalized Periodontitis

  • Authors: Parkhomenko Daria; Igor Belenichev; Kuchkovskyi Oleh; Ryzhenko Victor
  • Journal: MicroRNA
  • Year: 2024

Comparative Analysis of the Effect of Beta Blockers of Different Generations on the Parameters of Myocardial Energy Metabolism in Experimental Doxorubicin-Induced Chronic Heart Failure

  • Authors: Igor Belenichev; Olexiy Goncharov; Nina Bukhtiyarova; Oleh Kuchkovskyi; Victor Ryzhenko; Lyudmyla Makyeyeva; Valentyn Oksenych; Oleksandr Kamyshnyi
  • Journal: Preprint
  • Year: 2024

Development and Optimization of Nasal Composition of a Neuroprotective Agent for Use in Neonatology after Prenatal Hypoxia

  • Authors: Igor Belenichev; Olena Aliyeva; Bogdan Burlaka; Kristina Burlaka; Oleh Kuchkovskyi; Dmytro Savchenko; Valentyn Oksenych; Oleksandr Kamyshnyi
  • Journal: Pharmaceuticals
  • Year: 2024